4 ms·
Public health outcomes. The model would be something like the UK's NICE. It has many fewer perverse incentives than the current model (which focusses on disease
by adw 8y ago
Public health outcomes. The model would be something like the UK's NICE. It has many fewer perverse incentives than the current model (which focusses on diseases of wealth).
It's not at all clear that it wouldn't be markedly more efficient in terms of public health outcomes.
- refurb 8y agoHow do you apply NICE’s framework to in early R&D when you have no idea what the clinical benefit might be?